Bytes Technology Ltd (BYIT)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 455.20 |
|---|---|
| 52-week range | 248.60 – 494.20 |
| Return, 1 month / 3 months | +0.8% / +8.7% |
| Return, 1 year / 3 years | +25.6% / +6.8% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 35.8% |
| Worst drawdown (1 year) | -31.6% |
| Average daily value traded | 326.20M GBX |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bytes Technology Ltd is a software and cloud services business based in the United Kingdom. It supplies organisations with software licences, mainly for Microsoft products, along with security tools and cloud solutions. Its customers include companies and public sector bodies, which it serves through account teams and technical specialists. The company also offers related services such as consultancy, support and managed cloud hosting, helping clients choose, deploy and run their information technology systems.
Bytes Technology Ltd trades under the code BYIT on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bytes Technology Ltd (BYIT) trades on the London Exchange in UK. It last closed at GBX 455.20 on 22 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 242 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.6% and over the last three months it rose 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.3% | ||
| From 52-week high | -1.5% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.7% | ||
| 6-month return | 46.9% | ||
| 12-month return, skipping the last month | 24.6% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.6% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 326.20M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | +0.8% |
| 3 months | +8.7% |
| 6 months | +46.9% |
| 1 year | +25.6% |
| 3 years | +6.8% |
| 5 years | +5.7% |
Signals
| 50-day / 200-day average | 429.52 / 360.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 19.87 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Nov 2026 | GBP 0.0330 |
| 16 Jul 2026 | GBP 0.0700 |
| 6 Nov 2025 | GBP 0.0320 |
| 10 Jul 2025 | GBP 0.1690 |
| 7 Nov 2024 | GBP 0.0310 |
| 18 Jul 2024 | GBP 0.1470 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.